Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma
暂无分享,去创建一个
[1] G. Du,et al. HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma , 2023, Biomarker Research.
[2] Shiyi Sun,et al. Integrating single-cell analysis and machine learning to create glycosylation-based gene signature for prognostic prediction of uveal melanoma , 2023, Frontiers in Endocrinology.
[3] Hao Jiang,et al. Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma , 2023, Frontiers in Immunology.
[4] Guobin Song,et al. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing , 2023, Frontiers in Immunology.
[5] Jinhui Liu,et al. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity , 2023, Frontiers in Immunology.
[6] F. Gao,et al. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer , 2023, Frontiers in Endocrinology.
[7] Ke Su,et al. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease , 2023, Frontiers in Immunology.
[8] M. Toh,et al. Global epidemiology and genetics of hepatocellular carcinoma. , 2023, Gastroenterology.
[9] Kyoung Song,et al. Modulating Glycolysis to Improve Cancer Therapy , 2023, International journal of molecular sciences.
[10] F. Greten,et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade , 2023, Gut.
[11] A. Teichmann,et al. Exosomes: A potential tool for immunotherapy of ovarian cancer , 2023, Frontiers in Immunology.
[12] C. Guha,et al. Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines , 2023, Cancer management and research.
[13] Jun Wang,et al. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis , 2022, Scientific reports.
[14] Xiaosong Li,et al. Ensemble deep learning enhanced with self-attention for predicting immunotherapeutic responses to cancers , 2022, Frontiers in Immunology.
[15] G. Du,et al. LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance , 2022, Genes & diseases.
[16] Xiaosong Li,et al. IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines? , 2022, Frontiers in Immunology.
[17] H. Cortez‐Pinto,et al. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors , 2022, Nature reviews. Gastroenterology & hepatology.
[18] Wenyi Jin,et al. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature , 2022, Frontiers in Endocrinology.
[19] Gang Tian,et al. Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC , 2022, Frontiers in Immunology.
[20] Yueqiu Gao,et al. Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy , 2022, Journal of hepatocellular carcinoma.
[21] A. Grant,et al. PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation , 2022, Cellular and molecular gastroenterology and hepatology.
[22] Cong Yu,et al. The prognostic value of MicroRNAs associated with fatty acid metabolism in head and neck squamous cell carcinoma , 2022, Frontiers in Genetics.
[23] Li-chao Pan,et al. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma , 2022, World journal of gastroenterology.
[24] Yue Zhao,et al. A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration , 2022, Frontiers in Genetics.
[25] Y. Tong,et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. , 2022, Cell metabolism.
[26] Xuesu Xiao,et al. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer , 2022, Cell Death & Disease.
[27] M. Vacca,et al. Metabolic dysfunction and cancer in HCV: shared pathways and mutual interactions. , 2022, Journal of hepatology.
[28] H. Reeves,et al. Neutrophils as potential therapeutic targets in hepatocellular carcinoma , 2022, Nature Reviews Gastroenterology & Hepatology.
[29] M. Tsuboi,et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. , 2022, Cancer cell.
[30] Shinichi Nakagawa,et al. NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis. , 2021, Cell metabolism.
[31] A. Dohan,et al. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma? , 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[32] V. Mazzaferro,et al. Immunotherapies for hepatocellular carcinoma , 2021, Nature Reviews Clinical Oncology.
[33] A. Bazhin,et al. The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies , 2021, Frontiers in Oncology.
[34] A. Tsung,et al. Regulatory T cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. , 2021, Journal of hepatology.
[35] J. Yun,et al. TPI1‐reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis , 2021, Journal of extracellular vesicles.
[36] Peng Huang,et al. Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives , 2021, Cancer management and research.
[37] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[38] P. Vaupel,et al. Revisiting the Warburg effect: historical dogma versus current understanding , 2020, The Journal of physiology.
[39] Huanming Yang,et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma , 2020, Cell.
[40] Jing Luo,et al. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma , 2020, Cell Death & Disease.
[41] Yumin Li,et al. The advances in immunotherapy for hepatocellular carcinoma , 2020 .
[42] W. Dai,et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma , 2020, Journal of Experimental & Clinical Cancer Research.
[43] Hao Peng,et al. Exploration of the molecular characteristics of the tumor–immune interaction and the development of an individualized immune prognostic signature for neuroblastoma , 2020, Journal of cellular physiology.
[44] M. Kudo,et al. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. , 2020, Journal of hepatology.
[45] W. Dai,et al. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis , 2020, Journal of Experimental & Clinical Cancer Research.
[46] Lan Zhang,et al. Lactic acid promotes macrophage polarization through MCT-HIF1α signaling in gastric cancer. , 2020, Experimental cell research.
[47] Guodong Liu,et al. M2 Macrophages Promote HCC Cells Invasion and Migration via miR-149-5p/MMP9 Signaling , 2020, Journal of Cancer.
[48] Gregory J. Gores,et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management , 2019, Nature Reviews Gastroenterology & Hepatology.
[49] S. Fu,et al. Emerging roles of aerobic glycolysis in breast cancer , 2019, Clinical and Translational Oncology.
[50] Xiaowu Xu,et al. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. , 2019, Cancer letters.
[51] Hong Tang,et al. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression , 2019, Journal of Hematology & Oncology.
[52] Peter Vaupel,et al. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression , 2019, International journal of radiation biology.
[53] N. Tang,et al. Recent Advances in HBV Reactivation Research , 2018, BioMed research international.
[54] J. Llovet,et al. Molecular therapies and precision medicine for hepatocellular carcinoma , 2018, Nature Reviews Clinical Oncology.
[55] Zhongguo Zhou,et al. Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma , 2018, British Journal of Cancer.
[56] J. Rowe,et al. How does the tumor microenvironment play a role in hepatobiliary tumors? , 2018, Journal of gastrointestinal oncology.
[57] L. Galluzzi,et al. Mitochondrial metabolism and cancer , 2017, Cell Research.
[58] A. Sjölander,et al. M2‐like macrophages induce colon cancer cell invasion via matrix metalloproteinases , 2017, Journal of cellular physiology.
[59] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[60] W. Stein,et al. The transport of sugars. , 1968, British medical bulletin.
[61] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[62] Jean Claude Zenklusen,et al. A Practical Guide to The Cancer Genome Atlas (TCGA) , 2016, Statistical Genomics.
[63] Huafeng Zhang,et al. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression , 2015, Cellular and Molecular Life Sciences.
[64] J. Mesirov,et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.
[65] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.